false
Catalog
The Liver Meeting 2020
Postgraduate Course - Part 2 Paradigm Shifts in He ...
Postgraduate Course - Part 2 Paradigm Shifts in Hepatology: Rethinking Conventional Wisdom
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
Treatment of portal vein thrombosis in cirrhotic patients involves individualized care based on factors like thrombosis extent, symptoms, and transplant status. Consideration of risks and benefits of anticoagulation is crucial, with monitoring for clinical improvement being essential. Addressing contributing factors like protein C deficiency is necessary. Collaboration between medical and interventional approaches is effective in management.<br /><br />Hepatitis C treatment advancements have led to high cure rates, but public health challenges remain for its elimination. Continued surveillance, monitoring post-treatment liver health, and implementing screening protocols are key. To reach WHO's elimination goals by 2030, improving medical practices, blood safety, and treatment access is vital. Successful programs in regions like Egypt have shown significant reductions in hepatitis C cases, while in the US, rising mortality rates pose challenges. Strategies like expanded testing, harm reduction services, and vaccination are crucial in the fight against hepatitis C. Advancements in hepatitis B treatment and considerations for liver disease patients during the COVID-19 pandemic are also highlighted.<br /><br />Investing in public health programs and innovative tools is essential to eliminate hepatitis globally and address the impact of COVID-19 on liver health.
Keywords
portal vein thrombosis
cirrhotic patients
anticoagulation
thrombosis extent
transplant status
protein C deficiency
medical intervention
Hepatitis C treatment
cure rates
public health challenges
WHO elimination goals
blood safety
screening protocols
hepatitis B treatment
COVID-19 pandemic
×
Please select your language
1
English